Information on the Target

EMSA Capital has successfully divested FAMED Żywiec, a prominent manufacturer of high-quality medical equipment based in Poland, to BHM Group, a private equity firm from the Czech Republic. Since its acquisition by EMSA, FAMED has revitalized its operations and significantly increased its profitability, establishing itself as a reputable player in the medical equipment sector. The company employs nearly 300 individuals and has expanded its reach, becoming an internationally recognized brand across more than 112 countries.

FAMED Żywiec specializes in supplying medical institutions with a range of essential products, including hospital beds, operating tables, and treatment chairs. In recognition of its commitment to high-quality standards and environmentally friendly manufacturing processes, FAMED was awarded the Factory of the Year in the Green Factory category in Poland in 2019. For more details, visit: www.famed.com.pl.

Industry Overview in Poland

Poland's medical equipment industry has shown substantial growth in recent years, driven by increasing healthcare expenditures and a rising demand for quality healthcare services. This sector is characterized by innovation and the introduction of advanced technologies aimed at improving patient outcomes. The growing population and aging demographic are also contributing factors to the expansion of medical facilities and, consequently, the need for high-quality medical equipment.

Furthermore, Poland benefits from a strong educational framework that spurs medical research and development, thus fostering a conducive environment for medical equipment manufacturers. Local companies are continually investing in the enhancement of their production capabilities and the adoption of contemporary manufacturing practices.

Moreover, the COVID-19 pandemic has further highlighted the importance of well-equipped healthcare systems, prompting both government and private sector investments aimed at upgrading medical facilities. This has translated into increased sales for manufacturers like FAMED, which are positioned to meet the surging demand for reliable medical equipment.

In addition, Poland's strategic location within Europe makes it an attractive hub for export-oriented manufacturers. Companies can leverage this geographical advantage to reach different markets while capitalizing on the growing demand for medical supplies across the continent.

The Rationale Behind the Deal

The acquisition of FAMED by BHM Group aligns with their strategy to invest in companies with strong growth potential within the healthcare sector. FAMED's robust product portfolio and its established market presence make it an ideal target for investment. Following the successful restructuring and growth initiated by EMSA Capital, BHM Group sees opportunity in further enhancing FAMED's operations and expanding its international footprint.

Additionally, this divestment allows EMSA Capital to realize a return on its investment while enabling FAMED to leverage BHM Group's resources and expertise to navigate future developments in the medical equipment landscape.

Information About the Investor

BHM Group is a Czech private equity firm with a focus on investing in mid-sized companies with significant growth potential across various industries, including healthcare. Their investment philosophy emphasizes collaboration with management teams to enhance operational performance and drive sustainable growth. With a proven track record of successfully managing and scaling companies, BHM Group is well-suited to elevate FAMED's business further.

The firm's experience in the healthcare sector, coupled with its strategic approach to investment, positions it to support FAMED's aspirations for expansion and innovation in a rapidly evolving market.

View of Dealert

From an expert perspective, this deal represents a compelling investment opportunity for BHM Group. FAMED has demonstrated a strong recovery and growth trajectory under EMSA Capital, establishing itself as a noteworthy player in the international medical equipment market. The company's reputation for quality and sustainability aligns well with ongoing trends in healthcare, making it an attractive asset.

The healthcare industry in Poland is poised for further expansion, driven by various macroeconomic factors, including increased healthcare spending and an aging population. As FAMED continues to innovate and enhance its offerings, BHM Group's expertise is likely to yield successful synergies that promote long-term value creation.

Furthermore, the alignment of BHM Group's resources with FAMED’s operations could result in accelerated market penetration and product development, positioning the company favorably against competitors. This strategic acquisition is set to not only benefit BHM Group but also contribute substantively to the Polish healthcare landscape.

In conclusion, this investment holds significant promise, and the effective management by BHM Group could lead to an expansion of FAMED's operations and market presence both within Poland and internationally.

View Original Article